| Literature DB >> 25371805 |
Seyedeh Mahsan Hoseini Alfatemi1, Mohammad Motamedifar2, Nahal Hadi1, Hadi Sedigh Ebrahim Saraie1.
Abstract
BACKGROUND: Staphylococcus aureus is amongst major human pathogens both in hospitals and the community. This bacterium is an opportunistic pathogen responsible for a large number of self-limiting and even life-threatening diseases in humans. Methicillin resistant S. aureus (MRSA) strains are common causes of emerging nosocomial infections and are considered as a major problem for public health.Entities:
Keywords: Iran; Methicillin-resistant Staphylococcus aureus
Year: 2014 PMID: 25371805 PMCID: PMC4217665 DOI: 10.5812/jjm.10741
Source DB: PubMed Journal: Jundishapur J Microbiol ISSN: 2008-3645 Impact factor: 0.747
The Oligonucleotide Sequences and Amplicon Size of Each Gene Used in This Study (19, 20)
| Oligonucleotide Sequence (5’-3’) | Amplicon Size, bp | |
|---|---|---|
|
| 102 | |
| GSEAR-1 | GGTTATCAATGTGCGGGTGG | |
| GSEAR-2 | CGGCACTTTTTTCTCTTCGG | |
|
| 164 | |
| GSEBR-1 | GTATGGTGGTGTAACTGAGC | |
| GSEBR-2 | CCAAATAGTGACGAGTTAGG | |
|
| 278 | |
| GSEDR-1 | CCAATAATAGGAGAAAATAAAAG | |
| GSEDR-2 | ATTGGTATTTTTTTTCGTTC | |
|
| 326 | |
| GTSSTR-1 | ACCCCTGTTCCCTTATCATC | |
| GTSSTR-2 | TTTTCAGTATTTGTAACGCC | |
|
| 93 | |
| GETAR-1 | GCAGGTGTTGATTTAGCATT | |
| GETAR-2 | AGATGTCCCTATTTTTGCTG | |
|
| 226 | |
| GETBR-1 | ACAAGCAAAAGAATACAGCG | |
| GETBR-2 | GTTTTTGGCTGCTTCTCTTG | |
|
| 443 | |
| PVL-1 | ATCATTAGGTAAAATGTCTGGACATGATCCA | |
| NPVL-2 | GCATCAAGTGTATTGGATAGCAAAAGC | |
|
| 209 | |
| HLA-1 | CTGATTACTATCCAAGAAATTCGATTG | |
| HLA-2 | CTTTCCAGCCTACTTTTTTATCAGT | |
|
| 111 | |
| HLD-1 | AAGAATTTTTATCTTAATTAAGGAAGGAGTG | |
| HLD-2 | TTAGTGAATTTGTTCACTGTGTCGA | |
|
| 147 | |
| MECA-1 | GTGAAGATATACCAAGTGATT | |
| MECA-2 | ATGCGCTATAGATTGAAAGGAT |
The Control Strains Used in this Study for Each Toxin Gene of S. aureus
| Strain Names | Target Genes |
|---|---|
|
|
|
|
| MRSA, |
|
| |
|
|
The Amount of Injected Water for Dilution of Primers to a Concentration of 100 pM
| Primer Name | µL of Water |
|---|---|
|
| 166.03 |
|
| 367.59 |
|
| 190.23 |
|
| 200.96 |
|
| 270.46 |
|
| 535.28 |
|
| 174.45 |
|
| 346.17 |
|
| 359.54 |
|
| 369.59 |
|
| 192.28 |
|
| 340.52 |
|
| 155.89 |
|
| 234.71 |
|
| 219.50 |
|
| 181.48 |
|
| 240.84 |
|
| 262.45 |
|
| 304.94 |
|
| 197.89 |
Reagents Used for PCR of All Genes Except for LukS/F-PV Gene
| Materials | Volume Used, µL | Concentrations |
|---|---|---|
|
| 1 | 200 µm |
|
| 1.5 | 1.5 mM |
|
| 2.5 | 1 X |
|
| 1 | 10 pmol/µL |
|
| 1 | 10 pmol/µL |
|
| 0.25 | 1 unit |
|
| 14.75 | - |
|
| 3 | - |
|
| final volume = 25 | - |
Reagents Used for PCR of LukS/F-PV Gene
| Materials (Co. Name, Country) | Volume Used, µL | Concentration |
|---|---|---|
|
| 1.5 | 200 µM |
|
| 1 | 1.5 mM |
|
| 2.5 | 1 X |
|
| 1 | 10 pmol/µL |
|
| 1 | 10 pmol/µL |
|
| 0.5 | 1 unit |
|
| 15.5 | - |
|
| 2 | - |
|
| final volume = 25 | - |
Thermal Cycler Programs Used in This Study
| Cycle Number | Time | Temperature, °C | Definite | Steps | Programs |
|---|---|---|---|---|---|
|
| 5 min | 94 | Initial denaturation | 1 | program 1 |
|
| 30 sec | 95 | Denaturation | 1 | program 2 |
|
| 45 sec | 50-60 [ | Annealing | 2 | program 2 |
|
| 1 min | 72 | Extension | 3 | program 2 |
|
| 7 min | 72 | final extension | 1 | program 3 |
a Change in range is inserted suit to different genes. Annealing temperature for the genes were followed as: eta and etb (54°C); tst, mecA, sed and seb (50°C); LukS/F-PV and sea (60°C); hla and hld (58°C).
Figure 1.The Frequency of Isolates Collected From Different Sources of Infection
Figure 2.Patterns of Agarose Gel Electrophoresis Showing PCR Amplification Products for the Isolated S. aureus Genes.
Lanes M, DNA molecular size marker (100-bp ladder; Cinna Gen, Iran); C-: negative control; lane 1: tst; lane 2: LukS /F-PV; lane 3: sed; lane 4: etb; lane 5: seb; lane 6: hla
Figure 3.Patterns of Agarose Gel Electrophoresis Showing PCR Amplification Products for the Isolated S. aureus Genes.
Lanes M, DNA molecular size marker (50-bp ladder; Cinna Gen, Iran); C-: negative control; lane 1: eta; lane 2: sea; lane 3: hld
Prevalence of Various Genes of MRSA Isolated From Different Specimens
| Source |
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
| 13 | 3 | - | 3 | - | - | - | 56 | 50 |
|
| 4 | 6 | 1 | 5 | - | 1 | 2 | 17 | 16 |
|
| 5 | 1 | - | 4 | 1 | 1 | 3 | 19 | 18 |
|
| 3 | - | - | 1 | - | 1 | - | 3 | 3 |
|
| - | - | - | - | - | - | - | 3 | 1 |
|
| 1 | - | - | - | - | - | - | 4 | 2 |
|
| 5 | - | - | - | - | - | - | 11 | 13 |
|
| 3 | 4 | 2 | 4 | - | - | 3 | 8 | 5 |
|
| - | - | - | - | - | - | - | 3 | 3 |
|
| 4 | 1 | - | - | - | - | - | 5 | 4 |
|
| 2 | 1 | - | - | - | - | - | 7 | 8 |
|
| 27.39 | 10.95 | 2.05 | 11.64 | 0.68 | 2.05 | 5.47 | 93.15 | 84.24 |
Distribution of Toxin Genes Among Methicillin-Resistant S. aureus Isolated From Different Specimens [a]
| Specimens | ET (n = 6) [ | S (n = 58) | W (n = 18) | B (n = 20) | N (n = 3) | E (n = 3) | T (n = 4) | U (n = 14) | Sk (n = 8) | BF (n = 4) | O (n = 8) |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| - | 4 | - | 1 | - | 2 | 2 | 1 | - | - | - |
|
| - | 1 | - | 1 | - | - | - | 1 | - | - | 1 |
|
| 1 | 35 | 6 | 7 | - | 1 | 1 | 7 | - | 3 | 5 |
|
| 1 | 2 | - | - | - | - | - | - | - | - | - |
|
| - | 1 | - | - | - | - | - | - | - | - | - |
|
| - | 1 | - | - | - | - | - | 2 | - | - | - |
|
| 2 | 9 | 1 | 3 | 1 | - | 1 | 3 | - | - | 1 |
|
| - | 2 | 2 | - | - | - | - | - | - | - | - |
|
| - | 2 | 2 | 2 | - | - | - | - | - | - | - |
|
| - | - | - | 1 | - | - | - | - | - | - | - |
|
| - | - | - | 1 | - | - | - | - | - | - | - |
|
| - | - | 1 | 1 | - | - | - | - | - | - | - |
|
| - | - | 1 | - | - | - | - | - | - | - | - |
|
| - | - | - | - | - | - | - | - | 1 | - | - |
|
| - | - | - | - | - | - | - | - | 1 | - | - |
|
| - | - | - | - | 1 | - | - | - | - | - | - |
|
| - | - | 1 | - | - | - | - | - | - | - | - |
|
| - | - | - | 1 | - | - | - | - | - | - | - |
|
| - | - | - | 1 | - | - | - | - | 1 | - | - |
|
| 1 | - | - | - | - | - | - | - | - | - | 1 |
|
| - | - | - | - | - | - | - | - | 1 | - | - |
|
| - | - | 1 | - | 1 | - | - | - | 1 | - | - |
|
| - | - | - | 1 | - | - | - | - | - | - | - |
|
| - | - | 1 | - | - | - | - | - | - | - | - |
|
| - | 1 | 1 | - | - | - | - | - | 1 | - | - |
|
| - | - | 1 | - | - | - | - | - | 2 | - | - |
a Abbreviations: B, blood; BF, body fluid; E, Eye; ET, endotracheal tube; N, nose; O, other; Sk, skin; S, sputum; T, throat; U, Urine; W, Wound.
b Among ET and BF specimens only in one specimen no toxin genes were present.